2023 - Research.com Best Scientist Award
2023 - Research.com Medicine in United States Leader Award
2022 - Research.com Best Scientist Award
In his works, John D. Minna undertakes multidisciplinary study on Gene and Cell. Borrowing concepts from Gene, John D. Minna weaves in ideas under Cell. He integrates Cancer with Cancer research in his research. His multidisciplinary approach integrates Cancer research and Lung cancer in his work. John D. Minna integrates many fields in his works, including Lung cancer and Lung. As part of his studies on Lung, he often connects relevant areas like Small-cell carcinoma. His Small-cell carcinoma study frequently links to other fields, such as Small Cell Lung Carcinoma. His Small Cell Lung Carcinoma study frequently involves adjacent topics like Pathology. His Pathology study typically links adjacent topics like Carcinoma.
John D. Minna performs multidisciplinary studies into Genetics and Allele in his work. His study ties his expertise on Immunoprecipitation together with the subject of Biochemistry. In his papers, John D. Minna integrates diverse fields, such as Immunoprecipitation and Molecular biology. John D. Minna integrates Molecular biology and Virology in his studies. His work often combines Virology and Immunology studies. In his research, he performs multidisciplinary study on Immunology and Cell biology. With his scientific publications, his incorporates both Cell biology and Biophysics. John D. Minna integrates Biophysics and DNA in his studies. As part of his studies on DNA, John D. Minna frequently links adjacent subjects like clone (Java method).
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
Bernard J. Poiesz;Francis W. Ruscetti;Adi F. Gazdar;Paul A. Bunn.
Proceedings of the National Academy of Sciences of the United States of America (1980)
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
James Carmichael;William G. DeGraff;Adi F. Gazdar;John D. Minna.
Cancer Research (1987)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
Hisayuki Shigematsu;Hisayuki Shigematsu;Li Lin;Takao Takahashi;Masaharu Nomura.
Journal of the National Cancer Institute (2005)
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
Frank Cuttitta;Desmond N. Carney;James Mulshine;Terry W. Moody.
p53: a frequent target for genetic abnormalities in lung cancer
Takashi Takahashi;Marion M. Nau;Itsuo Chiba;Michael J. Birrer.
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski.
BRAF and RAS mutations in human lung cancer and melanoma
Marcia S. Brose;Patricia Volpe;Michael Feldman;Madhu Kumar.
Cancer Research (2002)
Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir;Barbara A. Weir;Michele S. Woo;Gad Getz;Sven Perner;Sven Perner.
A small-cell lung cancer genome with complex signatures of tobacco exposure
Erin D. Pleasance;Philip J. Stephens;Sarah O’Meara;Sarah O’Meara;David J. McBride.
High-throughput oncogene mutation profiling in human cancer
Roman K. Thomas;Alissa C. Baker;Ralph M. DeBiasi;Ralph M. DeBiasi;Wendy Winckler;Wendy Winckler.
Nature Genetics (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: